Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment

Treatment of adolescents with early-onset schizophrenia spectrum disorders

(2013) Benno G. Schimmelmann et al.   CURRENT OPINION IN PSYCHIATRY

National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics

(2012) Mark Olfson et al.   ARCHIVES OF GENERAL PSYCHIATRY

Safety and tolerability of antipsychotic polypharmacy

(2012) Juan A Gallego et al.   Expert Opinion On Drug Safety

Treatment of Maladaptive Aggression in Youth: CERT Guidelines II. Treatments and Ongoing Management

(2012) N. Scotto Rosato et al.   PEDIATRICS

Prevalence and correlates of antipsychotic polypharmacy: A systematic review and meta-regression of global and regional trends from the 1970s to 2009

(2012) Juan A. Gallego et al.   SCHIZOPHRENIA RESEARCH

Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: A review of the randomized controlled studies

(2011) Alessandro Zuddas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Developments in Pediatric Psychopharmacology

(2011) Christoph U. Correll et al.   JOURNAL OF CLINICAL PSYCHIATRY

Antipsychotic Treatment Among Youth in Foster Care

(2011) S. dosReis et al.   PEDIATRICS

10-Year trends in the treatment and outcomes of patients with first-episode schizophrenia

(2010) J. Nielsen et al.   ACTA PSYCHIATRICA SCANDINAVICA

Anticholinergic Use in Children and Adolescents After Initiation of Antipsychotic Therapy

(2010) Irene Seunghyun Hong et al.   ANNALS OF PHARMACOTHERAPY

Antipsychotic polypharmacy in the treatment of children and adolescents in the fee-for-service component of a large state medicaid program

(2010) Robert J. Constantine et al.   CLINICAL THERAPEUTICS

Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons

(2010) David Fraguas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Advantages and disadvantages of combination treatment with antipsychotics

(2009) Guy Goodwin et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Broadened Use Of Atypical Antipsychotics: Safety, Effectiveness, And Policy Challenges

(2009) Stephen Crystal et al.   HEALTH AFFAIRS

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Psychiatrists’ attitude towards and knowledge of clozapine treatment

(2009) J. Nielsen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Antipsychotic Use in Children and Adolescents: Minimizing Adverse Effects to Maximize Outcomes

(2009) CHRISTOPH U. CORRELL et al.   JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY

Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and Adolescents

(2008) Roger S. McIntyre et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Adverse events in children and adolescents treated with antipsychotic medications

(2008) Jeanette M. Jerrell et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled Trials

(2008) C. U. Correll et al.   SCHIZOPHRENIA BULLETIN

Prescribing Patterns and the Use of Therapeutic Drug Monitoring of Psychotropic Medication in a Psychiatric High-Security Unit

(2008) Ingrid Castberg et al.   THERAPEUTIC DRUG MONITORING

Antipsychotic Treatment in Child and Adolescent First-Episode Psychosis: A Longitudinal Naturalistic Approach

(2007) Josefina Castro-Fornieles et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY